Approval · Notice of Compliance 179 · 2004
CERETEC: Notice of Compliance 179
Issued January 20, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 179
- Date
- January 20, 2004
- Company
- Amersham Health Inc.Mississauga, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Reagent for preparation of a radiodiagnostic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CERETEC | Not yet assigned | — |
Medicinal ingredients
- TECHNETIUM-99M EXAMETAZIME 0.5 MG per VIAL